Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is an open labeled phase II single arm trial. The patients with clinical stage II and
III will undergo core-needle biopsy of breast tumor for histologic diagnosis,
immunohistochemical studies for estrogen receptor (ER), progesterone receptor(PR), HER-2/neu
and others. PET or ultrasound results will determine the positivity of lymph node metastasis.